openPR Logo
Press release

Chronic Lymphocytic Leukemia Therapeutics Market Industry Professionals Like Abbvie ,Teva Pharmaceutical Industries, Biogen Idec, AstraZeneca, Arno Therapeutics, Genzyme Corporation, Gilead Sciences

04-20-2019 12:52 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Chronic Lymphocytic Leukemia Therapeutics

Chronic Lymphocytic Leukemia Therapeutics

Chronic lymphocytic leukemia (CLL) is a most common type of leukemia found in adults. It is a kind of malignancy characterized by production of abnormal white blood cells in the bone marrow. Symptoms include, swelling of the lymph nodes, fatigue, fever, infection, pain beneath the ribs, and weight loss. Although CLL is rarely seen in children and people under age 40, it is more prevalent in geriatric population. Moreover, causes of CLL are largely unknown and it is more severe than acute leukemia. The prevalence of CLL is high in males than females. Although, the incidence of this disorder is higher in white population than Asian populations, the precise cause for this cannot be explained.

The diagnosis of CLL includes Blood Cell Count and Examination, Bone Marrow Examination for patients followed by treatment. The treatment includes single or combination drug therapy, targeted therapies, monoclonal antibody therapies, white blood cell (neutrophil) growth factors. In addition to this, there are radiation therapy and splenectomy which are rarely used for the treatment.

Chronic Lymphocytic Leukemia Therapeutics Market - Drivers

High prevalence of CLL coupled with its high mortality rate, demonstrates the unmet market need for better therapeutics. According to the American Cancer Society (ACS) estimates, around 20,110 new cases of chronic lymphocytic leukemia and 4,660 deaths from CLL is expected in year 2017 in U.S. Furthermore, high prevalence of CLL in geriatric population is expected to increase demand for chronic lymphocytic leukemia therapeutics. According to the United Nations data, in 2015, around 901 million people in the world were over 60 years of age and this number is expected to reach 1.4 billion by 2030 and to 2.1 billion by 2050. However, continuous research and development may contribute to the development of new treatments related to malignancies, including impaired immune system, genetic factors, and viruses. Thus expected to boost the market growth during the forecast period.

Request For Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/2049

Furthermore, increasing number of incidences of comorbidities, especially among geriatric population and launch of new pipeline drugs are major factors contributing to growth of the chronic lymphocytic leukemia therapeutics market. For instance, on December 8, 2015, Bendeka injection—manufactured under the collaboration of Teva Pharmaceuticals Industries Ltd. and Eagle Pharmaceuticals Inc. acquired approval from FDA for the treatment of patients with CLL and indolent B-cell non-Hodgkin lymphoma (NHL) — progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

However, high costs and side effects associated with these drugs is expected to restrain growth of the market over the forecast period.

Chronic Lymphocytic Leukemia Therapeutics Market – Regional Analysis

On the basis of region, the chronic lymphocytic leukemia therapeutics market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America accounted for the largest market share in 2016 due to the presence of breakthrough pipeline drugs. For instance, the drug Acalabrutinib—manufactured by Acerta Pharma BV—is under phase 2 clinical trial for the treatment of CLL and small lymphocytic lymphoma (SLL) and the study is expected to complete in January 2019

Increasing research activities along with increasing prevelance of CLL in US expected to propel the growth of CLL in North America. According to the Leukemia & Lymphoma Society, US, there are 119,386 patients in 2013 which has been increased to 15,720 in 2014.

Chronic Lymphocytic Leukemia Therapeutics Market – Competitor Analysis

Major players operating in the chronic lymphocytic leukemia therapeutics market include, F. Hoffmann-La Roche Ltd, Novartis International AG, GlaxoSmithKline Pharmaceuticals Limited, Celgene Corporation, Genmab A/S, Abbvie Inc. Teva Pharmaceutical Industries Ltd., Biogen Idec, AstraZeneca plc, Arno Therapeutics, Genzyme Corporation, Gilead Sciences INC., and others.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2049

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Lymphocytic Leukemia Therapeutics Market Industry Professionals Like Abbvie ,Teva Pharmaceutical Industries, Biogen Idec, AstraZeneca, Arno Therapeutics, Genzyme Corporation, Gilead Sciences here

News-ID: 1711461 • Views:

More Releases from Coherent Market Insights

Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clasado Biosciences, VW-Ingredients, Shandong Longli Biotechnology Co., Ltd, Prenexus Health., Ingredion, Tata Chemicals Ltd., Yakult Honsha Co., Ltd., Tate & Lyle, Roquette Frèr
Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clas …
Coherent Market Insights Published Most recent Prebiotics for Dietary Supplements Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business,
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., K
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca P …
Coherent Market Insights Published Most recent DNA Repair Drugs Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business, this
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, Manufacturing Process, Business Plan | Alpek S.A.B de C.V., RTP Company, BASF SE
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, M …
This comprehensive Report of the Polyethylene Terephthalate (PET) Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requirement | BASF SE, Occidental Chemical Corporation
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requi …
This comprehensive Report of the Chlorine Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size

All 5 Releases


More Releases for CLL

Chronic Lymphocytic Leukemia (CLL) Therapeutics Market - Epidemiology Analysis, …
The global chronic lymphocytic leukemia therapeutics market is expected to create more opportunities in oncology due to promising pipeline and positive clinical data of drug candidates. The existing drugs for the treatment of chronic lymphocytic leukemia is the be most effective treatment. The American Cancer Society, and other regulatory bodies are supporting the chronic lymphocytic leukemia therapeutics market by providing funding and grants. The market is being driven by different
Global Chronic Lymphocytic Leukemia (CLL) Drugs Market US$ 5.9 Billion by 2021
The global chronic lymphocytic leukemia (CLL) drugs market expected to reach US$ 5.9 billion by 2021, growing at CAGR 13.6% over the forecast period 2017-2021. Chronic lymphocytic leukemia is one of the most common forms of leukemia. American Cancer Society estimates about 20,110 new cases of chronic lymphocytic leukemia in the United States for 2017. CLL accounts for about one-quarter of the new cases of leukemia. The main treatments used
Relapsed Chronic Lymphocytic Leukemia (CLL) Market Size, Share - Global Industry …
Latest industry research report on: Global Relapsed Chronic Lymphocytic Leukemia Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. DelveInsight's,Relapsed Chronic Lymphocytic Leukemia (CLL)-Global API Manufacturers,Marketed and Phase III Drugs Landscape,2018" report provides comprehensive insights about marketed and Phase III products for Relapsed Chronic Lymphocytic Leukemia (CLL) . The report includes information of marketed products including their product description,patent details,forecasted sales till 2020 & API manufacturer
2017 Research Report on Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2
"Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Chronic Lymphocytic Leukemia (CLL) Therapeutics Devices Market Forecast 2017-202 …
Chronic Lymphocytic Leukemia (CLL) Therapeutics Devices Market Research 2017 A market study ” Global Chronic Lymphocytic Leukemia (CLL) Therapeutics Devices Market ” will help you understand, formulate and implement strategic decisions by offering critical data, insights and analysis from technology as well as commercial perspective on the Chronic Lymphocytic Leukemia (CLL) Therapeutics Devices market. It encloses an in-depth Research of the Chronic Lymphocytic Leukemia (CLL) Therapeutics Devices market state and the
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review H1 – 2017: Ma …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted